BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35341421)

  • 1. Breast Cancer Classification on Multiparametric MRI - Increased Performance of Boosting Ensemble Methods.
    Vamvakas A; Tsivaka D; Logothetis A; Vassiou K; Tsougos I
    Technol Cancer Res Treat; 2022; 21():15330338221087828. PubMed ID: 35341421
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parametric MRI lesion heterogeneity biomarkers for breast cancer diagnosis.
    Tsarouchi MI; Vlachopoulos GF; Karahaliou AN; Vassiou KG; Costaridou LI
    Phys Med; 2020 Dec; 80():101-110. PubMed ID: 33137621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automatic classification of breast lesions on multi-parameter MRI using a radiomics model with minimal number of stable, interpretable features.
    Zhang J; Zhan C; Zhang C; Song Y; Yan X; Guo Y; Ai T; Yang G
    Radiol Med; 2023 Feb; 128(2):160-170. PubMed ID: 36670236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
    Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
    J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance radiomic feature performance in pulmonary nodule classification and impact of segmentation variability on radiomics.
    Koo CW; Kline TL; Yoon JH; Vercnocke AJ; Johnson MP; Suman G; Lu A; Larson NB
    Br J Radiol; 2022 Dec; 95(1140):20220230. PubMed ID: 36367095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of pulmonary lesion based on multiparametric MRI: utility of radiomics and comparison of machine learning methods.
    Wang X; Wan Q; Chen H; Li Y; Li X
    Eur Radiol; 2020 Aug; 30(8):4595-4605. PubMed ID: 32222795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.
    Dalmiş MU; Gubern-Mérida A; Vreemann S; Bult P; Karssemeijer N; Mann R; Teuwen J
    Invest Radiol; 2019 Jun; 54(6):325-332. PubMed ID: 30652985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
    Pinker K; Moy L; Sutton EJ; Mann RM; Weber M; Thakur SB; Jochelson MS; Bago-Horvath Z; Morris EA; Baltzer PA; Helbich TH
    Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics methodology for breast cancer diagnosis using multiparametric magnetic resonance imaging.
    Hu Q; Whitney HM; Giger ML
    J Med Imaging (Bellingham); 2020 Jul; 7(4):044502. PubMed ID: 32864390
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of sureness in evaluating AI/CADx: Lesion-based repeatability of machine learning classification performance on breast MRI.
    Whitney HM; Drukker K; Vieceli M; Van Dusen A; de Oliveira M; Abe H; Giger ML
    Med Phys; 2024 Mar; 51(3):1812-1821. PubMed ID: 37602841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI.
    Li X; Chai W; Sun K; Zhu H; Yan F
    Magn Reson Imaging; 2024 Feb; 106():8-17. PubMed ID: 38035946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.